General Anaesthesia Market Analysis by Molecule (Propofol, Dexmedetomidine, Sevoflurane, Desflurane, Midazolam, Remifentanil), by Route of Administration (Inhalation, Intravenous), and by Region - Forecast to 2029

Request Sample Page

The global general anesthesia market size is estimated to be USD xx billion in 2021 and is expected to witness a CAGR of xx% during the forecast period. Rising surgical procedures and growing investment in R&D of anesthetic drugs is key driver for the growth of the global general anesthesia market. Additionally, the increase in safe medical awareness, government support, cross-infection cases during the COVID-19 pandemic, and growing geriatric population are some of the other drivers propelling the market growth. Nevertheless, the adverse reaction of anesthetic drugs on patient health expected to restrain the global market growth.

Global General Anaesthesia Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Molecule

Based on molecule, the market is segmented into propofol, dexmedetomidine, sevoflurane, desflurane, midazolam, and remifentanil. In 2021, the propofol segment accounted for the largest revenue share with lucrative CAGR during the forecast period. This is attributed to the rising application for in surgical procedures worldwide. Dexmedetomidine segment is projected to grow at a profitable CAGR during the forecast period. This is attributed to rising demand for this drug for the treatment and surgical procedure.

By Route of Administration

Based on route of administration, the market is categorized into inhalation and intravenous. In 2021, the intravenous segment accounted for the largest revenue share due to increasing application in surgeries worldwide. This segment is anticipated to grow at a lucrative CAGR during the forecast period, due to the its convenient use and cheaper attribute.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of leading biopharmaceutical companies, high investments in anesthetic drugs R&D, and advanced healthcare infrastructure in this region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the rising medical tourism, modernization in healthcare infrastructure, and strengthening economies in this region.

Competitor Insights

Some of the key players in the general anesthesia market are Endo International plc (Ireland); Pfizer Inc. (U.S.); Fresenius SE & Co. KGaA (Germany); Eisai Co., Ltd. (Japan); Mylan N.V. (U.S.); Hikma Pharmaceuticals plc (U.K.); Baxter International Inc. (U.S.); AstraZeneca plc (U.K.); and Abbott Laboratories (U.S.). The leading players operating in the general anesthesia industry are adopting various strategies including R&D investments, adaption of advanced techniques, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The general anesthesia market report is categorized into the following segments and subsegments:

General Anesthesia Market, By Molecule (Revenue, USD Billion, 2021 – 2029)

  • Propofol
  • Dexmedetomidine
  • Sevoflurane
  • Desflurane
  • Midazolam
  • Remifentanil

General Anesthesia Market, By Route of Administration (Revenue, USD Billion, 2021 – 2029)

  • Inhalation
  • Intravenous

General Anesthesia Market, By Region (Revenue, USD Billion, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of General Anesthesia Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: General Anaesthesia Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: General Anaesthesia
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: General Anaesthesia Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Molecule
    1. Propofol
      1. Propofol Market Forecast, 2021-2029 (USD Million)
    2. Dexmedetomidine
      1. Dexmedetomidine Market Forecast, 2021-2029 (USD Million)
    3. Sevoflurane
      1. Sevoflurane Market Forecast, 2021-2029 (USD Million)
    4. Desflurane
      1. Desflurane Market Forecast, 2021-2029 (USD Million)
    5. Midazolam
      1. Midazolam Market Forecast, 2021-2029 (USD Million)
    6. Remifentanil
      1. Remifentanil Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Route of Administration
    1. Inhalation
      1. Inhalation Market Forecast, 2021-2029 (USD Million)
    2. Intravenous
      1. Intravenous Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America General Anaesthesia Market
    1. North America General Anaesthesia Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
        2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
      2. S. General Anaesthesia Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
          2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
        2. Canada General Anaesthesia Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
            2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
  1. Europe General Anaesthesia Market
    1. Europe General Anaesthesia Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
        2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
      2. Germany General Anaesthesia Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
          2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
        2. UK General Anaesthesia Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
            2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
          2. France General Anaesthesia Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
              2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
            2. Spain General Anaesthesia Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
                2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
              2. Italy General Anaesthesia Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
                2. Rest of Europe General Anaesthesia Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
  1. Asia Pacific General Anaesthesia Market
    1. Asia Pacific General Anaesthesia Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
        2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
      2. Japan General Anaesthesia Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
          2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
        2. China General Anaesthesia Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
            2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
          2. India General Anaesthesia Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
              2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
            2. South Korea General Anaesthesia Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
                2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
                3. Market Size and Forecast by Device, 2021-2029 (USD Million)
              2. Australia General Anaesthesia Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
                2. Rest of Asia Pacific General Anaesthesia Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
  1. Latin America General Anaesthesia Market
    1. Latin America General Anaesthesia Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
        2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
      2. Brazil General Anaesthesia Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
          2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
        2. Mexico General Anaesthesia Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
            2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
          2. Argentina General Anaesthesia Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
              2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
            2. Rest of Latin America General Anaesthesia Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
                2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
  1. MEA General Anaesthesia Market
    1. MEA General Anaesthesia Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
        2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
      2. GCC General Anaesthesia Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
          2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
        2. South Africa General Anaesthesia Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
            2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
          2. Rest of MEA General Anaesthesia Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Molecule, 2021-2029 (USD Million)
              2. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Endo International plc (Ireland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    2. Pfizer Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    3. Fresenius SE & Co. KGaA (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    4. Eisai Co., Ltd. (Japan)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    5. Mylan N.V. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    6. Hikma Pharmaceuticals plc (U.K.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    7. Baxter International Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    8. AstraZeneca plc (U.K.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    9. Abbott Laboratories (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    10. Dilon Technologies, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Molecule Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports